摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,3,6-三溴苯甲酸 | 21739-99-1

中文名称
2,3,6-三溴苯甲酸
中文别名
——
英文名称
2,3,6-tribromobenzoic acid
英文别名
——
2,3,6-三溴苯甲酸化学式
CAS
21739-99-1
化学式
C7H3Br3O2
mdl
——
分子量
358.812
InChiKey
IUCILSOWKNCUOC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    381.3±42.0 °C(Predicted)
  • 密度:
    2.383±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.3
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    37.3
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

点击查看最新优质反应信息

文献信息

  • Preparation of aromatic and heteroaromatic carboxylic acids by catalytic ozonolysis
    申请人:——
    公开号:US20030216577A1
    公开(公告)日:2003-11-20
    A process for catalytically oxidizing alkylaromatic compounds of the formula (I) Ar—CH 2 —R where Ar is an optionally substituted, aromatic or heteroaromatic 5-membered or 6-membered ring or a ring system having up to 20 carbon atoms where Ar may optionally be fused to a C 1 -C 6 -alkyl group in which up to 2 carbon atoms may be replaced by a heteroatom, and R is hydrogen, phenyl, benzyl or heteroaryl, where the phenyl, benzyl or heteroaryl radicals may also be joined to Ar by a bridge, or R together with Ar forms an optionally substituted ring system which may contain one or more optionally substituted heteroatoms, to the corresponding aromatic or heteroaromatic carboxylic acids in a solvent with ozone in the presence of a transition metal catalyst and optionally in the presence of an acid at a temperature between −70° C. and 110° C. to the corresponding carboxylic acid.
    将式(I)中的烷基芳香化合物催化氧化为相应的芳香或杂芳羧酸的过程是在溶剂中,在存在过渡属催化剂和可选地存在酸的情况下,利用臭氧将式(I)中的化合物氧化为相应的芳香或杂芳羧酸的过程。其中,式(I)中Ar为可选地取代的芳香或杂芳5-或6-成员环或具有多达20个碳原子的环系统,其中Ar可选地与一个C1-C6-烷基基团融合,其中最多有2个碳原子可被杂原子取代;R为氢、苯基、苄基或杂芳基,其中苯基、苄基或杂芳基基团也可以通过桥连接到Ar,或R与Ar一起形成一个可选地取代的环系统,该环系统可以含有一个或多个可选地取代的杂原子,反应温度在-70°C至110°C之间。
  • HIGH YIELD SYNTHESIS METHODS FOR PRODUCING ORGANIC SALTS OF STRONTIUM
    申请人:Christgau Stephan
    公开号:US20090137678A1
    公开(公告)日:2009-05-28
    New organic salts of strontium and methods of synthesizing such salts with high purity, high yields and with short processing times, at neutral conditions and at low reaction temperature, such as a temperature at or below 50° C.
    新的有机盐及合成这种盐的方法,具有高纯度、高产率、短处理时间,在中性条件下以及低反应温度,如在50°C或以下的温度下。
  • [EN] STRONTIUM-CONTAINING COMPOUNDS FOR USE IN THE PREVENTION OR TREATMENT OF NECROTIC BONE CONDITIONS<br/>[FR] COMPOSES A BASE DE STRONTIUM DESTINES A ETRE UTILISES DANS LA PREVENTION OU LE TRAITEMENT DE CONDITIONS D'OS NECROTIQUES
    申请人:OSTEOLOGIX AS
    公开号:WO2005082385A1
    公开(公告)日:2005-09-09
    A method for the treatment and/or prophylaxis of an ostenonecrotic bone disease in a mammal in need thereof, such as, e.g., idiopathic or secondary osteonecrosis, avascular bone necrosis, glucocorticoid induced bone ischemia/osteonecrosis, Legg-Calve-Perthes disease and femoral head necrosis, the method comprising administering an effective dose of a strontium-containing compound (a) to the mammal. A method for the treatment and/or prophylaxis of an osteonecrotic bone disease, such as, e.g., idiopathic or secondary osteonecrosis, avascular bone necrosis, glucocorticoid induced bone ischemia/osteonecrosis and femoral head necrosis, in a mammal who is to be or is treated with a therapeutic agent (b) known to or suspected of inducing apoptosis and/or necrosis of bone cells, the method comprising administering a strontium-containing compound (a) in combination with (b).
    一种治疗和/或预防哺乳动物骨骼坏死性疾病的方法,例如特发性或继发性骨坏死、无血管性骨坏死、糖皮质激素诱导的骨缺血/骨坏死、莱格-卡尔韦-佩尔特斯病和股骨头坏死,该方法包括向哺乳动物投予含化合物(a)的有效剂量。一种治疗和/或预防骨骼坏死性疾病的方法,例如特发性或继发性骨坏死、无血管性骨坏死、糖皮质激素诱导的骨缺血/骨坏死和股骨头坏死,在将要或正在接受已知或疑似诱导骨细胞凋亡和/或坏死的治疗剂(b)的哺乳动物中,该方法包括给予含化合物(a)与(b)的组合。
  • High shear process for making metallic esters
    申请人:Dover Chemical Corporation
    公开号:EP1604969A1
    公开(公告)日:2005-12-14
    A process to make a metallic ester which comprises: (a) mixing at least one metallic salt with at least one partially heated acidic organic moiety form a heated slurry at a first temperature; (b) reacting said slurry under shear conditions to form a micro-emulsion for no longer than about two minutes at a second higher temperature to form a pumpable metallic ester; and (c) collecting said metallic ester.
    制备属酯的过程包括:(a)将至少一种属盐与至少一种部分加热的酸性有机基团混合形成一个在第一温度下加热的浆料;(b)在第二较高温度下,在剪切条件下反应该浆料,形成一个微乳液,反应时间不超过约两分钟,以形成可泵送的属酯;(c)收集所述属酯。
  • High Yield And Rapid Synthesis Methods For Producing Metallo-Organic Salts
    申请人:Christgau Stephan
    公开号:US20070282127A1
    公开(公告)日:2007-12-06
    A new method for preparing salts of metal cations and organic acids, especially divalent salts of alkaline earth metal ions from group II of the periodic system and carboxylic acids. The method comprising the use of a high temperature (about 90° or more) and, optionally. high pressure, in order to obtain a higher yield, purity and faster reaction speed than obtained with known synthesis methods. In particular, the present invention relates to the production of strontium salts of carboxylic acids. Novel strontium salts are also provided by the present method.
    一种制备属阳离子和有机酸盐的新方法,特别是来自周期表II组的碱土属离子的二价盐和羧酸。该方法包括使用高温(约90℃或更高)和可选的高压,以获得比已知合成方法更高的产量、纯度和更快的反应速度。特别是,本发明涉及羧酸盐的生产。本方法还提供了新型盐。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫